Condition
Refactory Childhood Acute Lymphoblastic Leukemia clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Refactory Childhood Acute Lymphoblastic Leukemia clinical trials that are recruiting, at sites in 2 countries (most in Thailand (1), United States (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
CD19-directed CAR T cells with IL-7Rα signaling for children with relapsed or refractory B-cell ALL
We will test whether a child's own T cells, changed to target CD19 and boost IL‑7 signaling, can safely treat children aged 1–18 with relapsed or refractory B-cell acute lymphoblastic leukemia.
-
Genetically engineered CAR T-cells for treating certain blood cancers
This study is testing a new type of treatment using specially modified immune cells to see if they can help people with certain blood cancers that haven't responded to other treatments.
Related topics
Quick answers
How many Refactory Childhood Acute Lymphoblastic Leukemia clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Thailand (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.